Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

multiple myeloma

  • You have access
    Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study
    Huishou Fan, Weida Wang, Ya Zhang, Jianxiang Wang, Tao Cheng, Lugui Qiu, Xin Wang, Zhongjun Xia and Gang An
    Cancer Biology & Medicine January 2023, 20 (1) 77-87; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0612
  • You have access
    JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ
    Zilu Zhang, Chenjing Ye, Jia Liu, Wenbin Xu, Chao Wu, Qing Yu, Xiaoguang Xu, Xinyi Zeng, Huizi Jin, Yingli Wu and Hua Yan
    Cancer Biology & Medicine May 2022, 19 (5) 651-668; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0473
  • You have access
    Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
    Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
    Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  • You have access
    Low Grade Fibromyxoid Sarcomas and Multiple Myeloma in the Same Patient: One Case Report and Literature Review
    Chong-mei HUANG, Shu-qing LÜ, Jian-min WANG, Xiao-xia HU, Li-li WU and Jian-min YANG
    Clinical Oncology and Cancer Research June 2010, 7 (3) 210-213; DOI: https://doi.org/10.1007/s11805-010-0520-1
  • You have access
    An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in the Chinese Population
    Yang Shen, Zhixiang Shen, Bin Jiang, Jian Hou, Rong Zhan, Lugui Qiu, Daobin Zhou, Jie Jin, Juan Li, Fanyi Meng, Ping Zou, Ting Liu, Jianyong Li, Chun Wang, Depei Wu and Jun Ma
    Clinical Oncology and Cancer Research December 2009, 6 (6) 394-400; DOI: https://doi.org/10.1007/s11805-009-0394-2
  • You have access
    Progress in Drug Therapy for Multiple Myeloma
    Shun’e Yang and Bing Zhao
    Chinese Journal of Clinical Oncology August 2008, 5 (4) 251-257; DOI: https://doi.org/10.1007/s11805-008-0251-8

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire